Infection Due to Hepatitis Delta Virus in Africa: Report from Senegal and Review

Authors:
  • JSJean-Louis Sankalé
    Jean-Louis Sankalé
  • FDFrédéric Dubois
    Frédéric Dubois
  • ADAlassane Diouf
    Alassane Diouf
  • ABAbdelkader Bacha
    Abdelkader Bacha
  • SMSouleymane Mboup
    Souleymane Mboup
  • AGAlain Goudeau
    Alain Goudeau

Abstract
A review of the literature shows strong variations in the prevalence of hepatitis delta virus (HDV) among Africans seropositive for hepatitis B surface antigen (HBsAg). In Senegal, West Africa, prevalence of antibodies to HDV among asymptomatic HBsAg carriers appears to be linked to regional and/or socioeconomic factors. Antibodies to HDV were found in 22 (47%) of 47 HBsAg-seropositive patients with liver disease who were hospitalized in the main hospital of Dakar and in 4% to 44% of asymptomatic HBsAg carriers. Eight (36%) of 22 patients with liver disease were seropositive for IgM antibodies to HDV, whereas none of 18 asymptomatic subjects were seropositive (P < .01). According to studies conducted in Europe and the United States, the presence of this marker may constitute support for the argument that HDV plays a role in the development of HBsAg-associated liver diseases in Senegal and, presumably, within the African continent.